| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 | 0.5 | −63.6% | |
| Gross profit | (0.1) | 0.0 | 0.0 | 0.0 | 0.0 | (1.4) | (0.5) | +63.6% | |
| Research & development | 3.7 | 28.0 | 62.7 | 102.5 | 118.1 | 62.0 | 40.8 | −34.2% | |
| Selling, general & administrative | 1.5 | 13.7 | 20.9 | 23.6 | 26.0 | 19.3 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 5.2 | 41.7 | 83.6 | 126.1 | 144.1 | 79.9 | 58.0 | −27.4% | |
| Operating income | (5.3) | (41.7) | (83.6) | (126.1) | (144.1) | (81.3) | (58.1) | +28.6% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.1 | 1.8 | 8.9 | 5.6 | 1.9 | — | — | |
| Other income / expense | 0.0 | 0.1 | 1.8 | 8.9 | 5.6 | 19.5 | — | — | |
| Pre-tax income | (5.3) | (41.6) | (81.8) | (117.3) | (138.4) | (61.8) | (32.5) | +47.3% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (5.3) | (41.6) | (81.8) | (117.3) | (138.4) | (61.8) | (32.5) | +47.3% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (0.50) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) | (0.50) | +57.9% | |
| EPS, diluted (per share) | (0.50) | (1.74) | (2.80) | (3.44) | (3.83) | (1.18) | (0.50) | +57.9% | |
| EBITDA | (5.2) | (41.3) | (81.1) | (115.7) | (136.7) | (60.4) | (57.2) | +5.3% | |
| Depreciation & amortization | 0.1 | 0.2 | 0.7 | 1.5 | 1.7 | 1.4 | 0.5 | −63.6% | |
| Weighted average shares (shares) | 10,708,048 | 23,858,552 | 29,271,777 | 34,106,923 | 36,105,671 | 52,228,068 | — | — | |
| Weighted average diluted shares (shares) | 10,708,048 | 23,858,552 | 29,271,777 | 34,106,923 | 36,105,671 | 52,228,068 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
